44
Participants
Start Date
August 31, 2017
Primary Completion Date
May 8, 2019
Study Completion Date
January 11, 2021
Zanubrutinib
Oral administration using 80 mg capsules
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Peking Union Medical College Hospital, Beijing
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
Jiangsu Province Hospital, Nanjing
The First Affiliated Hospital of Soochow University Branch Shizi, Suzhou
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan
Henan Cancer Hospital, Zhengzhou
Guangdong Provincial Peoples Hospital, Guangzhou
West China Hospital, Sichuan University, Chengdu
Lead Sponsor
BeiGene
INDUSTRY